Syndicated Report

InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 2

November 9, 2020

Given the recent uptick in COVID-19 cases in the US, many InCrowd panelists have been reporting that they do not expect things to return to normal until a vaccine is developed and disseminated. In order to deepen our understanding of the COVID-19 vaccine landscape, we surveyed infectious disease specialists across the country to get their perception and predictions on the efficacy, impact, and competitive landscape of COVID-19 vaccines.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.

Methodology:

  • Method:
    • 12-Minute MicroSurvey via InCrowd
  • Crowds:
    • Infectious disease doctors
  • Sample Size:
    • n = 100
      • Community Hospital, Academic Hospital, Office-based
  • Fielding Period:
    • October 22nd – 26th

InCrowd’s other COVID-19 Tracking Reports:

  • This field is for validation purposes and should be left unchanged.